Cargando…

Daratumumab-induced transient myopic shift

PURPOSE: To describe an unprecedented case of transient myopic shift induced by a chemotherapeutic agent, daratumumab. OBSERVATIONS: A 43-year-old emmetropic female with multiple myeloma experienced sudden onset of myopic shift during her first intravenous dose of daratumumab, an increasingly common...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mavrommatis, Maria A., Jung, Hoon, Chari, Ajai, Barlogie, Bart, Chelnis, James G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Case report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312830/ https://www.ncbi.nlm.nih.gov/pubmed/30619976 http://dx.doi.org/10.1016/j.ajoc.2018.12.017

Ejemplares similares

Cefixime-induced angle closure and transient myopic shift in a healthy individual; A case report
por: Mirshahi, Reza, et al.
Publicado: (2020)

Transient myopic shift due to ciliary body detachment as the sole ocular manifestation of hypertensive emergency – A case report
por: Chan, Wesley, et al.
Publicado: (2018)

Lupus-Induced Myopic Shift
por: Safari, Sara, et al.
Publicado: (2022)

Acute myopic shift in a patient with systemic lupus erythematosus
por: Yosar, Jason, et al.
Publicado: (2019)

Temporary Myopic Shift in a Patient with Multiple Parallel-Line Endotheliitis
por: Lee, Jee Hye, et al.
Publicado: (2023)

Subcutaneous daratumumab and hyaluronidase-fihj in newly diagnosed or relapsed/refractory multiple myeloma
por: Sanchez, Larysa, et al.
Publicado: (2021)

Acute transient macular detachment after uneventful cataract surgery in a highly myopic eye
por: Verdina, Tommaso, et al.
Publicado: (2021)

Cataract Surgery following Sequential Myopic and Hyperopic LASIK
por: Chia, Tao Ming Thomas, et al.
Publicado: (2018)

Paradoxical myopic shift following cycloplegia in retinopathy of prematurity patients: a case series
por: London, Nikolas JS, et al.
Publicado: (2009)

Acute bilateral angle closure induced by monoclonal antibody (Daratumumab) infusion
por: Saengsirinavin, Aim-on, et al.
Publicado: (2021)

Daratumumab for immune thrombotic thrombocytopenic purpura
por: van den Berg, Jana, et al.
Publicado: (2022)

Acute Myopic Shift and Internal Limiting Membrane Folds Linked to Topiramate Use: A Case Report
por: Dogan, Levent
Publicado: (2022)

Daratumumab: The perplexity in immunohematology with emerging horizons in myeloma therapy
por: Agrawal, Soma, et al.
Publicado: (2020)

Daratumumab/obinutuzumab: Various toxicities: 14 case reports
Publicado: (2021)

Daratumumab–bortezomib–dexamethasone use in relapsed POEMS syndrome
por: Khwaja, Jahanzaib, et al.
Publicado: (2022)

Thermal Ocular Surface Injury from Cooking Oil: Delayed Onset Transient Corneal Infiltration and Myopic Shift
por: Ahn, Jong Ho, et al.
Publicado: (2016)

Role of daratumumab in transfusion medicine: a must know entity
por: Subramaniyan, Rajeswari, et al.
Publicado: (2017)

Exposure‐Response and Population Pharmacokinetic Analyses of a Novel Subcutaneous Formulation of Daratumumab Administered to Multiple Myeloma Patients
por: Luo, Man (Melody), et al.
Publicado: (2020)

Results of an early access treatment protocol of daratumumab in United States patients with relapsed or refractory multiple myeloma
por: Chari, Ajai, et al.
Publicado: (2018)

Daratumumab for treatment-refractory acquired idiopathic pure red cell aplasia
por: Gangat, Naseema, et al.
Publicado: (2022)

Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS
por: Moreau, Philippe, et al.
Publicado: (2023)

Daratumumab Interferes with Allogeneic Crossmatch Impacting Immunological Assessment in Solid Organ Transplantation
por: Ho, Chak-Sum, et al.
Publicado: (2022)

Laboratory features of tumour lysis syndrome following daratumumab monotherapy in relapsed/refractory multiple myeloma
por: Shackleton, Louisa, et al.
Publicado: (2020)

Central retinal artery occlusion secondary to Barlow's disease
por: Wilkins, Carl S., et al.
Publicado: (2018)

Disseminated Cryptococcosis in a Patient with Multiple Myeloma Treated with Daratumumab, Lenalidomide, and Dexamethasone
por: Sato, Shuku, et al.
Publicado: (2018)

Myopic shift in a pseudophakic eye with an accommodating IOL following vitrectomy with gas tamponade
por: Aker, Jonathan, et al.
Publicado: (2018)

Deep sustained response to daratumumab monotherapy associated with T-cell expansion in triple refractory myeloma
por: Usmani, Saad Z., et al.
Publicado: (2018)

Daratumumab, lenalidomide, and dexamethasone in relapsed/refractory myeloma: a cytogenetic subgroup analysis of POLLUX
por: Kaufman, Jonathan L., et al.
Publicado: (2020)

Efficacy and Safety of Durvalumab Combined with Daratumumab in Daratumumab-Refractory Multiple Myeloma Patients
por: Frerichs, Kristine A., et al.
Publicado: (2021)

The importance of ganglion cell complex investigation in myopic patients
por: Strehaianu, Maria Veronica, et al.
Publicado: (2017)

Chorioretinal Atrophy after Spontaneous Resolution of Myopic Foveoschisis
por: García-Ben, Antonio, et al.
Publicado: (2014)

Three cases of macular retinal detachment exacerbated during follow-up with myopic foveoschisis around myopic choroidal neovascularization()()
por: Sayanagi, Kaori, et al.
Publicado: (2023)

Durable treatment response of relapsing CNS plasmacytoma using intrathecal chemotherapy, radiotherapy, and Daratumumab
por: Elhassadi, Ezzat, et al.
Publicado: (2018)

Daratumumab‐based induction and autologous transplantation in concomitant multiple myeloma and chronic myeloid leukemia
por: Liberatore, Carmine, et al.
Publicado: (2023)

Efficacy and Safety of Daratumumab, Pomalidomide, and Dexamethasone (DPd) Compared to Daratumumab, Bortezomib, and Dexamethasone (DVd) in Daratumumab–Naïve Relapsed Multiple Myeloma
por: Afrough, Aimaz, et al.
Publicado: (2023)

Daratumumab plus lenalidomide/bortezomib/dexamethasone in Black patients with transplant-eligible newly diagnosed multiple myeloma in GRIFFIN
por: Nooka, Ajay K., et al.
Publicado: (2022)

Single intravitreal ranibizumab for myopic choroidal neovascularization
por: Nor-Masniwati, Saidin, et al.
Publicado: (2011)

LONGITUDINAL CHANGES IN CHOROIDAL AND RETINAL THICKNESSES IN CHILDREN WITH MYOPIC SHIFT
por: Jin, Peiyao, et al.
Publicado: (2019)

Refractory IgD Multiple Myeloma Treated with Daratumumab: A Case Report and Literature Review
por: Husnain, Muhammad, et al.
Publicado: (2016)

Interference of daratumumab with pretransfusion testing, mimicking a high-titer, low avidity like antibody
por: Lin, Mei-Hwa, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0et6qa9ghl75m7aeina07gboee